COVID-19 Vaccine

Man receiving COVID vaccine

COVID-19 Vaccine

UPDATE: The FDA and CDC have authorized a third dose of the mRNA COVID-19 vaccines — Pfizer-BioNTech and Moderna — for immunocompromised individuals. Moffitt will offer the shot to eligible patients and staff. Check here for the latest updates.

Starting Aug. 24, we will hold vaccination clinics at two locations:

8:30 a.m.-4 p.m. Monday-Friday, Stabile Research Building atrium
*Starting Sept. 4: 7:30 a.m.-3 p.m. Saturday, Blood Draw

8:30 a.m.-4 p.m. Monday-Friday, *Room 2201 on the second floor (formerly Lori’s Gifts) next to Rehab Services & PAT
*Please check in first with Central Registration on the first floor 

A third dose of the Pfizer or Moderna vaccine is recommended for people who are moderately or severely immunocompromised. This includes:

  • Patients who are currently receiving medications to actively treat a cancer or were given those treatments in the past 12 months.
  • Patients currently undergoing radiation therapy or who had undergone radiation treatments in the past 12 months.
  • Patients with severe primary immunodeficiency syndromes such as DiGeorge and Wiskott-Aldrich.
  • Patients who are actively being treated with high dose corticosteroids equivalent to at least 20 milligrams of prednisone daily.
  • Patients who are actively being treated with Tumor Necrosis Factor (TNF) blockers used for autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, Crohn’s disease and others. These drugs include Humira, Cimzia, Enbrel, Simponi, Remicade and their biosimilars.
  • Patients who have undergone solid organ transplants and who are on immunosuppressive medications.
  • Blood and marrow transplant patients and those who have undergone CAR T-cell therapy should discuss with their treating physician whether the timing is right for them to receive a third dose.
  • Patients being treated for malignant hematology conditions should also discuss with their treating physician whether the timing is right for a third dose.

Additional criteria:

  • You must bring proof of receiving the Pfizer or Moderna vaccine to be eligible for a third dose of the same kind.
  • For the Johnson & Johnson vaccine: The FDA and CDC say a booster will likely be needed eight months after vaccination. If you received this vaccine, be prepared to return to your original vaccination site or another community site.

Scheduling your third dose:

To check your eligibility, please send a message to your health care team through the MyMoffitt Patient Portal or call 813-745-8000 to have a message relayed to your provider. Please bring your vaccine card to be signed. You will also receive a printed confirmation of your third dose.

Scheduling your first dose:


The FDA has granted full approval of the Comirnaty Pfizer-BioNTech two-dose vaccine for people 16 and older. If you are a Moffitt patient and would like to schedule your first dose of the vaccine, please call 813-745-8000.

Moffitt preparing for booster shots for individuals who are not considered immunocompromised:

  • For patients who are not deemed immunocompromised, the FDA and CDC have also announced plans to authorize a booster shot for everyone who received the Pfizer or Moderna vaccines. These booster shots would start Sept. 20 and be offered to individuals once they are at least eight months out from receiving their second dose. Individuals would receive the same type of vaccine.
  • Moffitt is planning to offer these booster shots to patients, staff and others who were given their initial vaccinations at the cancer center.
  • More details to come.

The COVID-19 vaccines are among the most effective and safest vaccines ever developed. The FDA has granted full approval of the Comirnaty Pfizer-BioNTech two-dose vaccine for people 16 and older. Both the Pfizer and Moderna vaccines are shown to be approximately 95% effective. It is safe for most cancer patients to receive the vaccine. However, for some patients in active treatment that causes immunosuppression, the vaccine may not be effective.

Moffitt is conducting research into the effectiveness and durability of the vaccine in cancer patients. If you have questions about the vaccine and how it fits within your treatment plan, please contact your care team through the message center within the MyMoffitt Patient Portal. Your care team will respond to your message after reviewing your medical history. For portal assistance, please call 813-745-8000.

It is also important not to delay any treatment for cancer in order to receive the COVID-19 vaccine.

If you are a cancer survivor, it should be safe for you to receive the vaccine. If you have concerns, talk to your oncologist or primary care physician.